TipRanks
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market
RNA
Atrium Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see RNA full AI Analyst Report?

Atrium Therapeutics, Inc. (RNA) Balance Sheet

23 Followers

Atrium Therapeutics, Inc. Balance Sheet

Atrium Therapeutics, Inc.'s total assets for Q2 2026 were $280.51M, a decrease of -4.05% from the previous quarter. RNA total liabilities were $65.94M for the fiscal quarter, a 13.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 278.35M$ 1.56B$ 628.55M$ 638.80M$ 427.58M
Total Liabilities
$ 71.07M$ 138.94M$ 127.79M$ 60.73M$ 46.15M
Total Equity Gross Minority
$ 207.29M$ 1.42B$ 500.76M$ 578.08M$ 381.43M
Other Metrics
Currency in USD

Atrium Therapeutics, Inc. Debt to Assets